CodeLab Capital enters into term sheet for the potential acquisition of healthcare software company

19 Jun 2026 11:13 CEST

Oslo, 19 June 2026

CodeLab Capital AS ("CodeLab" or the "Company") has entered into a non-binding
term sheet regarding the potential acquisition of 45% of the shares in a
Norwegian software and IT services company (the "Target").

The Target provides critical software to healthcare professionals, as well as a
broad range of IT services, including infrastructure, connectivity, and managed
services. The company has an established customer base and recurring revenues
across its business lines.

The potential transaction is a natural extension of CodeLab's existing
portfolio. Agil Helse and Kuba both operate in the occupational health and
safety segment, creating clear commercial synergies with the Target's healthcare
software. In addition, Cloudya's cloud and infrastructure capabilities align
closely with the Target's IT services business.

The transaction also marks a return to CodeLab Capital's roots, having
previously built and exited a cluster of leading Norwegian healthcare
businesses—including PatientSky, Programvareforlaget, Hove Medical, and
Infodoc—establishing deep domain expertise in healthcare software. Re-entering
this segment reflects the Company's conviction that meaningful value creation
opportunities remain in Norwegian digital health infrastructure.

Consideration is expected to be settled through a combination of cash and
shares, with shares comprising the majority of total consideration. The share
component is expected to be issued at a significant premium to CodeLab's current
trading price.

The potential acquisition remains subject to customary conditions, including
completion of due diligence and agreement on final transaction documentation.

CodeLab remains focused on executing its strategy of building a scalable
platform of companies with recurring revenues, attractive market positions, and
significant value creation potential through operational improvements and M&A.

Further updates will be provided as appropriate.

More information:
Access the news on Oslo Bors NewsWeb site